Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2011 Dec;26(8):627-30.
doi: 10.1177/1533317511432735. Epub 2012 Jan 31.

Association study of clusterin polymorphism rs11136000 with late onset Alzheimer's disease in Chinese Han population

Affiliations
Meta-Analysis

Association study of clusterin polymorphism rs11136000 with late onset Alzheimer's disease in Chinese Han population

Jian-Fang Ma et al. Am J Alzheimers Dis Other Demen. 2011 Dec.

Erratum in

  • Am J Alzheimers Dis Other Demen. 2013 Nov;28(7):715

Abstract

Objective: We conducted a case-control study to investigate whether clusterin polymorphism (rs11136000) was associated with late-onset Alzheimer's disease in Chinese Han population.

Methods: Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay was performed on genotype rs11136000 and APOEε4 in 127 patients with late-onset Alzheimer's disease and 143 control individuals. Previous published data from other Chinese samples was also included for further meta-analysis.

Results: APOEε4 was demonstrated to increase the risk of Alzheimer's disease in Chinese population (odds ratio = 2.35, 95% confidence interval: 1.40-3.96). There is no significant association between clusterin rs11136000 with late-onset sporadic AD in our small cohort. However, meta-analysis revealed significant allele and genotype differences between Alzheimer's disease and controls following a recessive model.

Conclusion: Clusterin (rs11136000) was associated with Alzheimer's disease in Chinese Han population.

PubMed Disclaimer

Conflict of interest statement

The authors declared no conflicts of interest with respect to the research, authorship, and/or publication of this article.

Similar articles

Cited by

References

    1. Dubois B, Feldman HH, Jacova C, et al. . Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734–746. - PubMed
    1. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7(3):137–152. - PMC - PubMed
    1. Raber J, Huang Y, Ashford J. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging. 2004;25(5):641–650. - PubMed
    1. Harold D, Abraham R, Hollingworth P, et al. . Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet. 2009;41(10):1088–1093. - PMC - PubMed
    1. Lambert JC, Heath S, Even G, et al. . Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet. 2009;41(10):1094–1099. - PubMed

Publication types

MeSH terms